| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3211815 | Journal of the American Academy of Dermatology | 2007 | 15 Pages |
Abstract
Through week 50, response was best maintained with continuous infliximab therapy. Infliximab was generally well-tolerated in most patients.
Keywords
PPDPASI 90PASI 75DLQIULNQOLALTPGATNFαQuality of lifeBSAASTAspartate aminotransferaseAlanine aminotransferasePhysician's Global AssessmentPASIEXPRESSTuberculosisanalysis of varianceANOVAtumor necrosis factor-alphaUpper limit of normalbody surface areaDermatology Life Quality Indexpurified protein derivativepsoriasis area and severity index
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Alan MD, Steven R. MD, PhD, Gerald D. MD, Kim MD, PhD, Robert PharmD, Cynthia MD, Shu MS, Lisa T. DrPH, Cynthia BS, Alice B. MD, PhD,